IMMUNOTAC

Silverback Therapeutics, Inc.

Application Filed: 2018-09-07
Trademark Application Details
Trademark Logo IMMUNOTAC

Mark For: IMMUNOTAC® trademark registration is intended to cover the categories of pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates. [all]

Status

2021-06-16 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88108651
Registration Number6707689
Mark Literal ElementsIMMUNOTAC
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeSERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-02-11
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 042 - Primary Class
  • (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameJoi A. White
Attorney Docket NumberT-4153/2 US
Law Office AssignedL90
Employee NameSTIGLITZ, SUSAN R

Timeline

2018-09-07Application Filed
2018-12-19Status: Live/Pending
2018-12-28Location: GENERIC WEB UPDATE
2019-01-02Transaction Date
2019-08-20Published
2019-08-20Published for Opposition
2020-02-11Location: INTENT TO USE SECTION
2021-02-10Status: A second request for extension of time to file a Statement of Use has been granted.
2022-04-19Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Silverback Therapeutics, Inc.
Address500 Fairview Avenue North, Suite 600 Seattle, WASHINGTON UNITED STATES 98109
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingIMAGE/JPEG2018-09-07
TEAS RF New ApplicationAPPLICATION/XML,IMAGE/JPEG2018-09-07
XSearch Search SummaryXML2018-12-18
Offc Action OutgoingXML2018-12-19
Administrative ResponseXML2018-12-28
Administrative ResponseXML2018-12-28
Response to Office ActionMULTI2019-06-18
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2019-06-20
TRAM Snapshot of App at Pub for OppostnMULTI2019-07-09
Notice of PublicationXML2019-07-31
Notification Of Notice of PublicationXML2019-07-31
OG Publication ConfirmationXML2019-08-20
Notice of AllowanceXML2020-02-11
Extension of Time to File SOUAPPLICATION/XML2020-08-03
ITU Extension ApprovalXML2020-08-05
ITU Unit ActionMULTI2020-08-05
Extension of Time to File SOUXML2021-02-10
ITU Extension ApprovalAPPLICATION/XML2021-02-12
ITU Unit ActionMULTI2021-02-12

Attorney of Record

JOI A. WHITE
CARR & FERRELL LLP
120 CONSTITUTION DRIVE
MENLO PARK, CA 94025

Good, Services, and Codes


IC 042. US 100 101. G & S: Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates

International Codes:42
U.S. Codes:100,101
Type CodeType
GS0421Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates
GS0421Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-02-12
TEAS EXTENSION RECEIVED2021-02-10
EXTENSION 2 GRANTED2021-02-1098765
EXTENSION 2 FILED2021-02-1098765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-08-05
TEAS EXTENSION RECEIVED2020-08-03
EXTENSION 1 GRANTED2020-08-0398765
EXTENSION 1 FILED2020-08-0398765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-02-11
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED2019-12-29
EXTENSION OF TIME TO OPPOSE RECEIVED2019-09-18
PUBLISHED FOR OPPOSITION2019-08-20
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-08-20
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-07-31
ASSIGNED TO LIE2019-07-1570633
APPROVED FOR PUB - PRINCIPAL REGISTER2019-07-08
TEAS/EMAIL CORRESPONDENCE ENTERED2019-06-1988889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-06-18
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-06-1888889
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN2018-12-3176487
LETTER OF PROTEST EVIDENCE FORWARDED2018-12-28
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-12-196325
NON-FINAL ACTION WRITTEN2018-12-1976487
NON-FINAL ACTION E-MAILED2018-12-196325
ASSIGNED TO EXAMINER2018-12-1876487
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-09-15
NEW APPLICATION ENTERED IN TRAM2018-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed